Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.70 |
| ▸ | CA2 | P00918 | 1/20 | 0.70 |
| ▸ | TYR | P14679 | 1/20 | 0.70 |
| ▸ | CA7 | P43166 | 1/20 | 0.70 |
| ▸ | CA9 | Q16790 | 1/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | TTR | P02766 | 1/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1972599 | 1.00 | CA12 (0.70) | CA12CA1CA2TYRCA7 | |
| SCHEMBL1564066 | 1.00 | CA12 (0.70) | CA12CA1CA2TYRCA7 | |
| SCHEMBL1842884 | 0.95 | CA12 (0.64) | CA12CA1CA2TYRCA7 | |
| SCHEMBL5057418 | 0.90 | CA12 (0.84) | CA12CA1CA2TYRCA7 | |
| SCHEMBL71224 | 0.90 | CA12 (0.84) | CA12CA1CA2TYRCA7 | |
| SCHEMBL23823901 | 0.87 | CA12 (0.54) | CA12CA1CA2TYRCA7 | |
| SCHEMBL29980425 | 0.87 | CA12 (0.54) | CA12CA1CA2TYRCA7 | |
| SCHEMBL776127 | 0.84 | HSD11B1 (0.67) | CA12CA1CA2TYRCA7 | |
| SCHEMBL21848007 | 0.84 | HSD11B1 (0.67) | CA12CA1CA2TYRCA7 | |
| SCHEMBL3748350 | 0.84 | ALDH1A1 (0.59) | CA12CA1CA2TYRCA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119695269-A | Solid polymer electrolyte membrane, method for producing the same, solid battery, and mechanical device | 重庆太蓝新能源有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-115594686-B | Millpulin A derivative, preparation method and medical application thereof | 沈阳药科大学 | 2023-10-13 | — | — | CN | claimed |
| CN-115594686-A | Millpuline A derivatives, and preparation method and medical application thereof | 沈阳药科大学（CN） | 2023-01-13 | — | — | CN | claimed |
| EP-3208301-B1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORP (JP) | 2019-04-03 | — | — | EP | claimed |
| US-10126478-B2 | Resin composition and optical compensation film using same | TOSOH CORPORATION (JP) | 2018-11-13 | — | — | US | claimed |
| US-20170242174-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORPORATION (JP) | 2017-08-24 | — | — | US | claimed |
| EP-3208301-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | Tosoh Corporation (JP) | 2017-08-23 | — | — | EP | claimed |
| JP-1135755-A | — | — | None | — | — | JP | disclosed |
| CN-119695269-A | Solid polymer electrolyte membrane, method for producing the same, solid battery, and mechanical device | 重庆太蓝新能源有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-115927221-B | Method for synthesizing methyl epoxycinnamate compound by biocatalysis | 湖南师范大学 | 2024-12-31 | — | — | CN | disclosed |
| CN-118530222-A | Pyrrolidine compound and application thereof | 上海交通大学医学院附属瑞金医院 | 2024-08-23 | — | — | CN | disclosed |
| CN-115594686-B | Millpulin A derivative, preparation method and medical application thereof | 沈阳药科大学 | 2023-10-13 | — | — | CN | disclosed |
| US-20230139593-A1 | TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2023-05-04 | — | — | US | disclosed |
| WO-2002068416-A2 | PROCESS OF PREPARING PAROXETINE AND INTERMEDIATES FOR USE THEREIN | SPURCOURT LIMITED (GB) | 2002-09-06 | — | — | WO | disclosed |
| US-5948914-A | PREPARING 4-(4-FLUOROPHENYL)-3-HYDROXYMETHYLPIPERIDINE BY OPTICALLY RESOLVING WITH O-CHLOROTARTRANILIC ACID; CHEMICAL INTERMEDIATE FOR DRUGS | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0812827-A1 | Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 1997-12-17 | — | — | EP | disclosed |
| US-4898609-A | HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1990-02-06 | — | — | US | disclosed |
| EP-0350012-A2 | Antiviral composition | MEIJI SEIKA KAISHA LTD. (JP) | 1990-01-10 | — | — | EP | disclosed |
| JP-H01135755-A | 4-CYANO-4-(FLUOROPHENYL)-3-(SUBSTITUTED PHENYL) BUTYRIC ACIDS, THEIR ESTERS AND DERIVATIVES, AND METHOD FOR SELECTIVELY CONTROLLING UNDESIRABLE VEGETATION IN RICE USING THE SAME | AMERICAN CYANAMID CO | 1989-05-29 | — | — | JP | disclosed |
| EP-0266725-A1 | 4-cyano-4-(fluorophenyl)-3-(substituted phenyl) butyric acids, esters and derivatives thereof, and a method of selectively controlling undesirable vegetation in rice therewith | AMERICAN CYANAMID COMPANY (US) | 1988-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139593-A1 | TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME | GPX4, TXNRD2, TXN2 | CA12 3466/4885CA1 3469/4885CA2 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.